Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The CXCL12/CXCR4/ACKR3 Axis in the Tumor Microenvironment: Signaling, Crosstalk, and Therapeutic Targeting
Martine J. Smit, Géraldine Schlecht‐Louf, María Neves, et al.
The Annual Review of Pharmacology and Toxicology (2020) Vol. 61, Iss. 1, pp. 541-563
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Exosome-guided bone targeted delivery of Antagomir-188 as an anabolic therapy for bone loss
Yan Hu, Xiaoqun Li, Qin Zhang, et al.
Bioactive Materials (2021) Vol. 6, Iss. 9, pp. 2905-2913
Open Access | Times Cited: 169
How chemokines organize the tumour microenvironment
Thorsten R. Mempel, Julia K. Lill, Lukas M. Altenburger
Nature reviews. Cancer (2023) Vol. 24, Iss. 1, pp. 28-50
Closed Access | Times Cited: 95
CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications
Yaru Yang, Jiayan Li, Wangrui Lei, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 11, pp. 3341-3359
Open Access | Times Cited: 70
The role and applications of extracellular vesicles in osteoporosis
Fei Fang, Jie Yang, Jiahe Wang, et al.
Bone Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 28
Spatial transcriptomics reveals that metabolic characteristics define the tumor immunosuppression microenvironment via iCAF transformation in oral squamous cell carcinoma
Zheqi Liu, Zhen Zhang, Yu Zhang, et al.
International Journal of Oral Science (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 20
New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine
Hanli Xu, Shuye Lin, Ziyun Zhou, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 7, pp. 739-776
Open Access | Times Cited: 32
Conformational dynamics underlying atypical chemokine receptor 3 activation
Omolade Otun, Christelle Aljamous, Elise Del Nero, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 30
Open Access | Times Cited: 9
Cryo-EM structure of monomeric CXCL12-bound CXCR4 in the active state
Yezhou Liu, Aijun Liu, Xinyu Li, et al.
Cell Reports (2024) Vol. 43, Iss. 8, pp. 114578-114578
Open Access | Times Cited: 8
Neoadjuvant chemotherapy-induced remodeling of human hormonal receptor-positive breast cancer revealed by single-cell RNA sequencing
Fang Jia, Shanshan Sun, Jiaxin Li, et al.
Cancer Letters (2024) Vol. 585, pp. 216656-216656
Open Access | Times Cited: 5
Applications of nanotechnology in remodeling the tumour microenvironment for glioblastoma treatment
Yulei Mu, Zhen Zhang, Huiqun Zhou, et al.
Biomaterials Science (2024) Vol. 12, Iss. 16, pp. 4045-4064
Closed Access | Times Cited: 5
Differential Involvement of ACKR3 C-Tail in β-Arrestin Recruitment, Trafficking and Internalization
Aurélien Zarca, Claudia V. Perez Almeria, Jelle van den Bor, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 618-618
Open Access | Times Cited: 29
Anticancer opportunities at every stage of chemokine function
Natalia V. Ortiz Zacarı́as, Martijn P. Bemelmans, Tracy M. Handel, et al.
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 11, pp. 912-928
Open Access | Times Cited: 28
Insulin-like growth factor 2 drives fibroblast-mediated tumor immunoevasion and confers resistance to immunotherapy
Daqiang Song, Yushen Wu, Jiakui Li, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 22
Open Access | Times Cited: 4
Spatial profiling identifies regionally distinct microenvironments and targetable immunosuppressive mechanisms in pediatric osteosarcoma pulmonary metastases.
Jason Eigenbrood, Nathan Wong, Paul Mallory, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Bisphenol A-Induced Cancer-Associated Adipocytes Promotes Breast Carcinogenesis Via CXCL12/AKT Signaling
Zhiyuan Dong, Liping He, Jin‐Yi Wu, et al.
Molecular and Cellular Endocrinology (2025), pp. 112473-112473
Closed Access
Pharmacological characterisation of a clinical candidate, TG-0054, a small molecule inverse agonist targeting CXCR4
Kylie S. Pan, Ziming Wang, Cy Pfeil, et al.
Molecular Pharmacology (2025), pp. 100015-100015
Closed Access
Structural basis of CXCR4 assembly and regulation
Aijun Liu, Yezhou Liu, Richard D. Ye
Cell Reports (2025) Vol. 44, Iss. 2, pp. 115255-115255
Open Access
Targeting the CXCR7 pathway with TC14012 to inhibit endothelial necroptosis and lung cancer metastasis
Huifeng Hao, Wenjia Tian, Jingjing Gong, et al.
Biochemical Pharmacology (2025), pp. 116852-116852
Closed Access
The association of SDF-1 and CXCR4 gene polymorphisms with rheumatoid arthritis susceptibility in the Iranian population
Shiva Aghaei, Mohammad Hossein Sahami-Fard, Saba Gharibi, et al.
Human Gene (2025), pp. 201402-201402
Closed Access
Targeting the chemokine receptor CXCR4 for cancer therapies
Ariana Rueda, Naroa Serna, Ramón Mangues, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Decidual CXCR4+CD56brightNK cells as a novel NK subset in maternal–foetal immune tolerance to alleviate early pregnancy failure
Tao Yu, Yanhong Li, Di Zhang, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 10
Open Access | Times Cited: 26
Chemotactic Recruitment of Genetically Engineered Cell Membrane-Camouflaged Metal−Organic Framework Nanoparticles for Ischemic Osteonecrosis Treatment
Hongyi Jiang, Weijie Xia, Tian Xia, et al.
Acta Biomaterialia (2024) Vol. 185, pp. 410-428
Closed Access | Times Cited: 3
Atypical opioid receptors: unconventional biology and therapeutic opportunities
Christie B. Palmer, Max Meyrath, Meritxell Canals, et al.
Pharmacology & Therapeutics (2021) Vol. 233, pp. 108014-108014
Open Access | Times Cited: 23
Peptide vaccine targeting mutatedGNAS: a potential novel treatment for pseudomyxoma peritonei
Kjersti Flatmark, Annette Torgunrud, Karianne G. Fleten, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 10, pp. e003109-e003109
Open Access | Times Cited: 18
GPC-100, a novel CXCR4 antagonist, improves in vivo hematopoietic cell mobilization when combined with propranolol
Devki Sukhtankar, Juan José Fung, Mi‐Na Kim, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0287863-e0287863
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top